Gevertz, J. L., Greene, J. M., Prosperi, S., Comandante-Lou, N., & Sontag, E. D. (2025). Understanding therapeutic tolerance through a mathematical model of drug-induced resistance. Npj Systems Biology and Applications, 11(1). https://doi.org/10.1038/s41540-025-00511-3

Nemzow, L., Boehringer, T., Mayenburg, J., Beaton-Green, L. A., Wilkins, R. C., & Turner, H. C. (2024). Interlaboratory comparison of high-throughput protein biomarker assay quantifications for radiation exposure classification. PLOS ONE, 19(4), e0301418. https://doi.org/10.1371/journal.pone.0301418

Cheng, Y. L., Banu, M. A., Zhao, W., Rosenfeld, S. S., Canoll, P., & Sims, P. A. (2024). Multiplexed single-cell lineage tracing of mitotic kinesin inhibitor resistance in glioblastoma. Cell Reports, 43(5), 114139. https://doi.org/10.1016/j.celrep.2024.114139

Deb, D., Zhu, S., LeBlanc, M. J., & Danino, T. (2022). Assessing chemotherapy dosing strategies in a spatial cell culture model. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.980770

Halatsch, M.-E., Dwucet, A., Schmidt, C. J., Mühlnickel, J., Heiland, T., Zeiler, K., Siegelin, M. D., Kast, R. E., & Karpel-Massler, G. (2021). In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma. Pharmaceuticals, 14(12), 1241. https://doi.org/10.3390/ph14121241